Behavioral health collaborative care for family members of ICU survivors in the Post-ICU clinic pilot
Official title: Integration of a Behavioral Health Collaborative Care Model Into an ICU Recovery Clinic-Pilot for Families
Run by Medical University of South Carolina · NCT07390786 · Data updated 2026-11-12
This pilot tests a telehealth-based behavioral health program using the NeuroFlow app for family members of ICU survivors to try to reduce anxiety, depression, and PTSD symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Medical University of South Carolina Academic / other |
| Locations | 1 site (Charleston, South Carolina) |
| Status | Recruiting |
| Started | January 30, 2026 |
| Main results expected | June 30, 2028 |
| Study ends | June 30, 2028 |
| Registry record updated | March 12, 2026 |
| Trial ID | NCT07390786 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking family members of patients seen in the MUSC ICU Recovery Clinic who have an internet-enabled device and do not have serious mental illness or severe cognitive impairment.
✕Probably not a fit
People with serious mental illnesses (e.g., schizophrenia, mania), late-stage dementia, limited English proficiency, no internet-enabled device, or who are prisoners are excluded and unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Family members of patients seen in the MUSC ICU Recovery Clinic will be invited to participate and randomized to an intervention group or an attention control group. The intervention group will receive telehealth-enabled behavioral health assessments and six months of access to the NeuroFlow platform as part of a Behavioral Health Collaborative Care Model, while the control group will receive symptom assessments without NeuroFlow access. Investigators will measure changes in depression, anxiety, and post-traumatic stress symptoms over six months, plus adherence, implementation metrics, and the type and amount of guided content used in NeuroFlow. A subset of participants will complete qualitative interviews to capture acceptability and suggestions for improvement.
Why it matters
Potential benefit: If successful, this approach could reduce symptoms of anxiety, depression, and PTSD among family members of ICU survivors and increase access to coordinated behavioral care through telehealth.
How similar studies have gone: Collaborative care models and digital/telehealth behavioral interventions have shown benefit for depression and anxiety in other populations, but applying a BH CoCM specifically to family members of ICU survivors is relatively novel with mainly preliminary evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Family member of ICU Recovery Clinic patient enrolled in parent BH CoCM study Exclusion Criteria: * Serious mental illness (e.g., schizophrenia, mania) * Late-stage dementia or cognitive impairment * Limited English proficiency * No internet-enabled device * Prisoners
Where it's running
-
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting
Study contacts
- Principal investigator: Rita Bakhru, MD — Medical University of South Carolina
- Study coordinator: Rita Bakhru, MD
- Email: recruitment@musc.edu
- Phone: 8437920965
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Behavioral health collaborative care for people recovering after ICU
This trial will test whether a coordinated behavioral health program using a digital app, coaching, and psychiatric support helps ICU survivors reduce anxiety, depression, and PTSD symptoms.
-
Psilocybin treatment for individuals with various psychiatric symptoms
This study is testing if a single dose of psilocybin can help people with different mental health issues like depression, anxiety, and PTSD feel better and improve their daily functioning.
-
Pre-visit Companion Brief: a primary care AI-assisted check for depression and anxiety
This pilot tests an AI-powered pre-visit assessment that creates a concise Companion Brief for clinicians to help identify depression and anxiety during routine primary care.
-
Mobile CBT for mood after a stroke
A mobile CBT app called Maya is tested to see if it helps adults recently recovering from stroke manage depression and anxiety during rehab.
-
Group-based ACT for psychological distress in young people
Researchers are testing whether group-based ACT helps 16-25 year olds with depression or anxiety more than the usual individual therapy.
-
Temporal Interference Neuromodulation for Anxiety and PTSD
Aimed at seeing whether temporal interference neuromodulation can help people with anxiety or PTSD by using scalp electrodes and brain imaging to monitor mood, physiology, and cognition.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.